Reduction in standard MAC and MAC for intubation after clonidine premedication in children

Area of Science:

• Anesthesiology
• Pediatric Anesthesia
• Pharmacology

Background:

• Clonidine is an alpha-2 adrenergic agonist with sedative and analgesic properties.
• Its potential to reduce anesthetic requirements in pediatric patients requires further investigation.

Purpose of the Study:

• To evaluate the dose-dependent effects of oral clonidine on the minimum alveolar concentration (MAC) for endotracheal intubation (MACEI) and skin incision (MAC) in children.

Main Methods:

• A randomized, placebo-controlled study involving 90 children (aged 2-8 years) receiving placebo, oral clonidine 2 µg/kg, or 4 µg/kg 100 minutes before anesthesia.
• Anesthesia was maintained with sevoflurane in oxygen and air. MAC values were determined using Dixon's up-and-down method.

Main Results:

• Mean MACEI decreased from 2.9% (placebo) to 2.5% (2 µg/kg) and 1.9% (4 µg/kg) (P < 0.05).
• Mean MAC decreased from 2.3% (placebo) to 1.8% (2 µg/kg) and 1.3% (4 µg/kg) (P < 0.05).
• The MACEI/MAC ratio remained unchanged.

Conclusions:

• Oral clonidine significantly reduces sevoflurane MAC requirements for intubation and skin incision in a dose-dependent manner in children.
• Clonidine demonstrates anesthetic-sparing effects without altering the ratio of MACEI to MAC.